Cargando…
Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States
Despite evidence that precision medicine (PM) results in improved patient care, the broad adoption and implementation has been challenging across the United States (US). To better understand the perceived barriers associated with PM adoption, a quantitative survey was conducted across five stakehold...
Autores principales: | Schroll, Monica M., Agarwal, Arushi, Foroughi, Olivia, Kong, Emily, Perez, Omar, Pritchard, Daryl, Breur, Tom, Garner Amanti, Kristen, Gustavsen, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316935/ https://www.ncbi.nlm.nih.gov/pubmed/35887521 http://dx.doi.org/10.3390/jpm12071025 |
Ejemplares similares
-
A Quantitative Framework for Measuring Personalized Medicine Integration into US Healthcare Delivery Organizations
por: Agarwal, Arushi, et al.
Publicado: (2021) -
Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer
por: Foroughi, Olivia, et al.
Publicado: (2023) -
Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study
por: Coert, Romée Melanie Helena, et al.
Publicado: (2021) -
A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies
por: Davies, Benjamin M, et al.
Publicado: (2017) -
Predictors of stakeholders’ intention to adopt nutrigenomics
por: Mustapa, Muhammad Adzran Che, et al.
Publicado: (2020)